{
    "2018-07-16": [
        [
            {
                "time": "2018-07-01",
                "original_text": "Analyst Recommendations for Valeant Pharmaceuticals in July",
                "features": {
                    "keywords": [
                        "Analyst",
                        "Recommendations",
                        "Valeant Pharmaceuticals"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "J&J's (JNJ) Invokana Label Expansion Filing Hit by FDA Delay",
                "features": {
                    "keywords": [
                        "J&J",
                        "Invokana",
                        "Label Expansion",
                        "FDA Delay"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "J&J's (JNJ) Invokana Label Expansion Filing Hit by FDA Delay",
                "features": {
                    "keywords": [
                        "J&J",
                        "Invokana",
                        "Label Expansion",
                        "FDA Delay"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "The Zacks Analyst Blog Highlights: PepsiCo, Eli Lilly, Broadcom, Biogen and Marathon",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "PepsiCo",
                        "Eli Lilly",
                        "Broadcom",
                        "Biogen",
                        "Marathon"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "consumer goods",
                        "biotech",
                        "semiconductors",
                        "pharmaceuticals",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}